Krka Delivers On Pledge To Publish Five-Year Business Plan

R&D, Sales Growth And EBITDA Among Key Strategic Objectives

Blue Arrows Rising up in wood blocks
Krka aims to be a leader in branded generics • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business